Correlation Between GlaxoSmithKline PLC and Software Effective

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Software Effective at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Software Effective into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Software Effective Solutions, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Software Effective and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Software Effective. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Software Effective.

Diversification Opportunities for GlaxoSmithKline PLC and Software Effective

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between GlaxoSmithKline and Software is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Software Effective Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Software Effective and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Software Effective. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Software Effective has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Software Effective go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Software Effective

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Software Effective. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 18.04 times less risky than Software Effective. The stock trades about -0.12 of its potential returns per unit of risk. The Software Effective Solutions is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1.50  in Software Effective Solutions on August 26, 2024 and sell it today you would lose (0.20) from holding Software Effective Solutions or give up 13.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Software Effective Solutions

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Software Effective 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Software Effective Solutions are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Software Effective revealed solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Software Effective Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Software Effective

The main advantage of trading using opposite GlaxoSmithKline PLC and Software Effective positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Software Effective can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Software Effective will offset losses from the drop in Software Effective's long position.
The idea behind GlaxoSmithKline PLC ADR and Software Effective Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets